These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 22832697

  • 1. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
    Ranke MB, Lindberg A, Brosz M, Kaspers S, Loftus J, Wollmann H, Kołtowska-Haggstrom M, Roelants M.
    Horm Res Paediatr; 2012; 78(1):8-17. PubMed ID: 22832697
    [Abstract] [Full Text] [Related]

  • 2. Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature: KIGS analysis and review.
    Ranke MB, Lindberg A.
    Horm Res Paediatr; 2011; 75(6):423-32. PubMed ID: 21358173
    [Abstract] [Full Text] [Related]

  • 3. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 4. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA.
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [Abstract] [Full Text] [Related]

  • 5. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone.
    Bang P, Bjerknes R, Dahlgren J, Dunkel L, Gustafsson J, Juul A, Kriström B, Tapanainen P, Aberg V.
    Horm Res Paediatr; 2011; 75(5):335-45. PubMed ID: 21228552
    [Abstract] [Full Text] [Related]

  • 6. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 7. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F, Lindberg A, Wilton P.
    Horm Res Paediatr; 2011 Apr; 76 Suppl 1():42-6. PubMed ID: 21778748
    [Abstract] [Full Text] [Related]

  • 8. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA.
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [Abstract] [Full Text] [Related]

  • 9. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
    Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertsson-Wikland K, Price DA, KIGS International Board. Kabi International Growth Study.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4212-8. PubMed ID: 11095456
    [Abstract] [Full Text] [Related]

  • 10. Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables.
    Ranke MB, Lindberg A, KIGS International Board.
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1229-37. PubMed ID: 20097713
    [Abstract] [Full Text] [Related]

  • 11. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W, Briody J, Moore B, Lu PW, Cowell CT.
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [Abstract] [Full Text] [Related]

  • 12. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS.
    Ranke MB, Lindberg A, Ferrández Longás A, Darendeliler F, Albertsson-Wikland K, Dunger D, Cutfield WS, Tauber M, Wilton P, Wollmann HA, Reiter EO, KIGS International Board.
    Pediatr Res; 2007 Jan; 61(1):105-10. PubMed ID: 17211150
    [Abstract] [Full Text] [Related]

  • 13. Analyses from a centre of short- and long-term growth in Turner's syndrome on standard growth hormone doses confirm growth prediction algorithms and show normal IGF-I levels.
    Ranke MB, Schweizer R, Martin DD, Ehehalt S, Schwarze CP, Serra F, Binder G.
    Horm Res Paediatr; 2012 Jan; 77(4):214-21. PubMed ID: 22433161
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Growth Hormone Results in Different Diagnosis and Trend Over 10 Year of Follow-up: A Single Center Experience.
    Aycan Z, Araslı Yılmaz A, Yel S, Savaş-Erdeve Ş, Çetinkaya S.
    J Clin Res Pediatr Endocrinol; 2021 Aug 23; 13(3):332-341. PubMed ID: 33749217
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS, Lundgren F.
    Horm Res; 2009 Jan 23; 71 Suppl 1():39-45. PubMed ID: 19153504
    [Abstract] [Full Text] [Related]

  • 16. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A, González L, Gunczler P, Lanes R.
    J Pediatr Endocrinol Metab; 2012 Jan 23; 25(7-8):651-7. PubMed ID: 23155689
    [Abstract] [Full Text] [Related]

  • 17. Is growth hormone treatment in children associated with weight gain?--longitudinal analysis of KIGS data.
    Reinehr T, Lindberg A, Koltowska-Häggström M, Ranke M.
    Clin Endocrinol (Oxf); 2014 Nov 23; 81(5):721-6. PubMed ID: 24750131
    [Abstract] [Full Text] [Related]

  • 18. Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome.
    Kaspers S, Ranke MB, Han D, Loftus J, Wollmann H, Lindberg A, Roelants M, Kleintjens J.
    Appl Health Econ Health Policy; 2013 Jun 23; 11(3):237-49. PubMed ID: 23649890
    [Abstract] [Full Text] [Related]

  • 19. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
    Blum WF, Cao D, Hesse V, Fricke-Otto S, Ross JL, Jones C, Quigley CA, Binder G.
    Horm Res; 2009 Jun 23; 71(3):167-72. PubMed ID: 19188742
    [Abstract] [Full Text] [Related]

  • 20. Predicting growth response among Egyptian prepubertal idiopathic isolated growth hormone deficient children.
    Salah N, Abd El Dayem SM, Fawaz L, Ibrahim M.
    J Pediatr Endocrinol Metab; 2013 Jun 23; 26(3-4):247-55. PubMed ID: 23337051
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.